414 related articles for article (PubMed ID: 1647553)
1. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
Salvemini D; de Nucci G; Vane JR
Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
[TBL] [Abstract][Full Text] [Related]
2. The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood.
Saniabadi AR; Lowe GD; Belch JJ; Forbes CD; Prentice CR; Barbenel JC
Thromb Haemost; 1983 Oct; 50(3):718-21. PubMed ID: 6196854
[TBL] [Abstract][Full Text] [Related]
3. Studies on the importance of the proposed release of nitric oxide from platelets.
Mollace V; Salvemini D; Vane J
Thromb Res; 1991 Dec; 64(5):533-42. PubMed ID: 1725563
[TBL] [Abstract][Full Text] [Related]
4. Platelet sensitivity in vitro to the prostacyclin analogue iloprost in diabetic patients.
Vicari AM; Macagni A; Pozza G
Horm Metab Res; 1989 Nov; 21(11):616-8. PubMed ID: 2480323
[TBL] [Abstract][Full Text] [Related]
5. Control of human and animal platelet aggregation by a new prostacyclin analog.
Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
[TBL] [Abstract][Full Text] [Related]
6. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
7. The role of prostaglandins in the ADP-induced aggregation of rabbit platelets shown by the use of 15-hydroxyprostaglandin dehydrogenase.
Wallis RB
Thromb Haemost; 1978 Jun; 39(3):725-32. PubMed ID: 705701
[TBL] [Abstract][Full Text] [Related]
8. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
Rendu F; Bachelot C; Molle D; Caen J; Guez D
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human platelet functions by verapamil.
Ikeda Y; Kikuchi M; Toyama K; Watanabe K; Ando Y
Thromb Haemost; 1981 Apr; 45(2):158-61. PubMed ID: 6789494
[TBL] [Abstract][Full Text] [Related]
10. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of ethanol on rabbit platelet aggregation, secretion of granule contents, and cyclic AMP levels in the presence of prostacyclin.
Rand ML; Gross PL; Jakowec DM; Packham MA; Mustard JF
Thromb Haemost; 1989 Apr; 61(2):254-8. PubMed ID: 2546284
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
[TBL] [Abstract][Full Text] [Related]
13. Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation--role of arachidonic acid metabolism.
Caccese D; Praticò D; Ghiselli A; Natoli S; Pignatelli P; Sanguigni V; Iuliano L; Violi F
Thromb Haemost; 2000 Mar; 83(3):485-90. PubMed ID: 10744158
[TBL] [Abstract][Full Text] [Related]
14. Effects of tris on responses of human and rabbit platelets to aggregating agents.
Packham MA; Guccione MA; Nina M; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1984 Apr; 51(2):140-4. PubMed ID: 6429880
[TBL] [Abstract][Full Text] [Related]
15. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
[TBL] [Abstract][Full Text] [Related]
16. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
[TBL] [Abstract][Full Text] [Related]
17. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and prostacyclin modulate the alterations in cardiac action potential duration mediated by platelets during ischaemia.
Goulielmos NV; Enayat ZE; Sheridan DJ; Cohen H; Flores NA
Cardiovasc Res; 1995 Nov; 30(5):788-98. PubMed ID: 8595628
[TBL] [Abstract][Full Text] [Related]
19. [Effect of heparin on platelet aggregation in vitro].
Róka L; Isert D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
[TBL] [Abstract][Full Text] [Related]
20. Human endothelial cells maintain anti-aggregatory activity for platelets during apoptosis.
Xu W; Favaloro EJ; Medbury H; Zoellner H
Thromb Haemost; 2001 May; 85(5):915-23. PubMed ID: 11372688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
